Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-023089
Filing Date
2020-02-03
Accepted
2020-02-03 17:25:35
Documents
10
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 6-K d870062d6k.htm 6-K 8567
2 EX-99.1 d870062dex991.htm EX-99.1 1193071
3 EX-99.2 d870062dex992.htm EX-99.2 40311
4 GRAPHIC g870062dsp03.jpg GRAPHIC 6785
5 GRAPHIC g870062dsp155.jpg GRAPHIC 5558
6 GRAPHIC g870062dsp156.jpg GRAPHIC 4472
7 GRAPHIC g870062dsp156a.jpg GRAPHIC 1387
8 GRAPHIC g870062dsp49.jpg GRAPHIC 27086
9 GRAPHIC g870062dsp64.jpg GRAPHIC 2525
10 GRAPHIC g870062dsp64_2.jpg GRAPHIC 14058
  Complete submission text file 0001193125-20-023089.txt   1329205
Mailing Address 35A ENGLISH DR. MONCTON A3 E1E 3X3
Business Address 35A ENGLISH DR. MONCTON A3 E1E 3X3 506-384-1571
ORGANIGRAM HOLDINGS INC. (Filer) CIK: 0001620737 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0831
Type: 6-K | Act: 34 | File No.: 001-38885 | Film No.: 20569761
SIC: 2834 Pharmaceutical Preparations